Skip to content

Ibogaine: all studies

Page 20 of 61: studies 191 to 200 of 610, newest first. Back to the ibogaine overview

Research

Ibogan, Aspidosperman, Vincamine, and Bisindole Alkaloids from a Malayan Tabernaemontana corymbosa: Iboga Alkaloids with C-20α Substitution.

Journal of Natural Products April 14, 2016 Choy-Eng Nge, Kam-Weng Chong, Noel F Thomas et al.

Ten new indole alkaloids (1-10) comprising five ibogan, two aspidosperman, one vincamine, and two bisindole alkaloids, in addition to 32 known alkaloids, were isolated from the stem-bark extract of a Malayan Tabernaemontana corymbosa. The structures of these alkaloids were determined based on analysis of the NMR and MS data and, in five instances (1, 3, 5, 6, 8), confirmed by X-ray diffraction...

Ibogaine-associated cardiac arrest and death: case report and review of the literature.

Therapeutic Advances in Psychopharmacology April 1, 2016 Jessica A Meisner, Susan R Wilcox, Jeremy B Richards 19 citations

A naturally occurring hallucinogenic plant alkaloid, ibogaine has been used as an adjuvant for opiate withdrawal for the past 50 years. In the setting of an escalating nationwide opiate epidemic, use of substances such as ibogaine may also increase. Therefore, familiarity with the mechanisms and potential adverse effects of ibogaine is important for clinicians. We present the case report of a...

DOI: 10.1177/2045125315626073 (opens in new tab) Full text (opens in new tab) Medication effects Ibogaine adverse effects Ibogaine complications Ibogaine side effects +11

Treatment of heroin dependence with ibogaine

European Psychiatry March 1, 2016 Arnt Schellekens, Toon Van Oosteren, Thomas Knuijver et al. 1 citation

Background The use of the hallucinogen ibogaine as an anti-addiction agent has been described in several case reports, dating back to the eighties. The anti-addiction properties of ibogaine have been confirmed in a large body of animal work. Ibogaine has been shown to be effective in reducing withdrawal severity and substance use for a variety of substances, including cocaine and opiates....

DOI: 10.1016/j.eurpsy.2016.01.799 (opens in new tab) Opiate Pharmacology Hallucinogen Heroin +1

Deconstructing the Iboga Alkaloid Skeleton: Potentiation of FGF2-induced Glial Cell Line-Derived Neurotrophic Factor Release by a Novel Compound.

ACS Chemical Biology January 15, 2016 Madalee M Gassaway, Teresa L Jacques, Andrew C Kruegel et al. 23 citations

Modulation of growth factor signaling pathways in the brain represents a new experimental approach to treating neuropsychiatric disorders such as depression, anxiety, and addiction. Neurotrophins and growth factors exert synaptic, neuronal, and circuit level effects on a wide temporal range, which suggests a possibility of rapid and lasting therapeutic effects. Consequently, identification of...

DOI: 10.1021/acschembio.5b00678 (opens in new tab) Full text (opens in new tab) Addiction Neuroprotection Brain protection Neurological protection +22

hERG Blockade by Iboga Alkaloids.

Cardiovascular toxicology 2016 Kenneth Alper, Rong Bai, Nian Liu et al. 35 citations

The iboga alkaloids are a class of naturally occurring and synthetic compounds, some of which modify drug self-administration and withdrawal in humans and preclinical models. Ibogaine, the prototypic iboga alkaloid that is utilized clinically to treat addictions, has been associated with QT prolongation, torsades de pointes and fatalities. hERG blockade as IKr was measured using the whole-cell...

DOI: 10.1007/s12012-015-9311-5 (opens in new tab) Full text (opens in new tab) Noribogaine 18-methoxycoronaridine 18-mc Toxicology Iboga alkaloids research +1

How toxic is ibogaine?

Clinical Toxicology 2016 Ruud P. W. Litjens, Tibor M Brunt 74 citations

Ibogaine is a psychoactive indole alkaloid found in the African rainforest shrub Tabernanthe Iboga. It is unlicensed but used in the treatment of drug and alcohol addiction. However, reports of ibogaine's toxicity are cause for concern. To review ibogaine's pharmacokinetics and pharmacodynamics, mechanisms of action and reported toxicity. A search of the literature available on PubMed was done,...

Functional neurotoxicity evaluation of noribogaine using video-EEG in cynomolgus monkeys.

Journal of pharmacological and toxicological methods 2016 Simon Authier, Michael V Accardi, Dominique Paquette et al. 10 citations

Continuous video-electroencephalographic (EEG) monitoring remains the gold standard for seizure liability assessments in preclinical drug safety assessments. EEG monitored by telemetry was used to assess the behavioral and EEG effects of noribogaine hydrochloride (noribogaine) in cynomolgus monkeys. Noribogaine is an iboga alkaloid being studied for the treatment of opioid dependence. Six...

DOI: 10.1016/j.vascn.2016.04.012 (opens in new tab) Full text (opens in new tab) Cynomolgus monkey Electroencephalography Pentylenetetrazol Noribogaine seizure safety +1

Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report.

Journal of Psychoactive Drugs 2016 Laurie Cloutier-Gill, Evan Wood, Trevor Millar et al. 22 citations

Opioid use disorders (OUD) translate into major health, social, and economic consequences. Opioid agonist medications, which generally require long-term administration, are the mainstay pharmacological treatment of OUD. However, a large proportion of individuals with OUD either refuse or fail to respond to these therapies. Ibogaine, a naturally occurring substance found in the Tabernanthe iboga...

DOI: 10.1080/02791072.2016.1180467 (opens in new tab) Full text (opens in new tab) Methadone maintance therapy Opioid agonist treatment Opioid use disorders Ibogaine treatment +7

Noribogaine is a G-protein biased κ-opioid receptor agonist.

Neuropharmacology December 1, 2015 Émeline L. Maillet, Nicolas Milon, Mari D. Heghinian et al. 59 citations

Noribogaine is the long-lived human metabolite of the anti-addictive substance ibogaine. Noribogaine efficaciously reaches the brain with concentrations up to 20 μM after acute therapeutic dose of 40 mg/kg ibogaine in animals. Noribogaine displays atypical opioid-like components in vivo, anti-addictive effects and potent modulatory properties of the tolerance to opiates for which the mode of...

DOI: 10.1016/j.neuropharm.2015.08.032 (opens in new tab) Full text (opens in new tab) 18-mc Analgesia Beta-arrestin pathway Biased agonist +19

Ibogaine: Suppressed Addiction Cure or Just Hype?

Journal of Psychology & Clinical Psychiatry November 23, 2015 Scott W Stern

Submit Manuscript | http://medcraveonline.com Ibogaine, illegal in United States, has been used for years in other countries.It is a compound derived from the Iboga plant and is a very powerful hallucinogen.It is described as a journey inside one’s mind where thoughts are clear to the addicted client.It is used on average of 1-3 times in the course of Ibogaine treatment according to patient and...

DOI: 10.15406/jpcpy.2015.04.00221 (opens in new tab) Addiction Social psychiatry Forensic psychiatry Psychoanalysis +2